Shaheen Nicholas J
Am J Gastroenterol. 2005 May;100(5):1009-11. doi: 10.1111/j.1572-0241.2005.41978.x.
The effect of a surgical antireflux procedure on the risk of cancer in those with GERD and Barrett's esophagus is unclear. Although some authorities have suggested that a surgical antireflux procedure might be superior to medical management for the prevention of cancer, the cumulative data do not demonstrate that those patients undergoing surgery have any decrement in cancer risk compared to those who receive medication. Most data available to assess the effect of surgery on cancer risk come from case series. These data are of very limited utility, because of differences in the baseline composition of groups undergoing medical and surgical therapy. Until more data are available, patients should not be advised to undergo surgical fundoplication as an antineoplastic measure.
手术抗反流治疗对胃食管反流病(GERD)和巴雷特食管患者患癌风险的影响尚不清楚。尽管一些权威人士认为,手术抗反流治疗在预防癌症方面可能优于药物治疗,但累积数据并未表明接受手术的患者与接受药物治疗的患者相比,患癌风险有任何降低。评估手术对癌症风险影响的现有数据大多来自病例系列研究。由于接受药物治疗和手术治疗的人群基线构成存在差异,这些数据的实用性非常有限。在获得更多数据之前,不应建议患者将手术胃底折叠术作为一种抗肿瘤措施。